BioClinica has named John Hubbard as its new CEO. Hubbard joins the company from Pfizer ($PFE), where he worked as senior vice president and worldwide head of development operations. The move sees Hubbard step back into the vendor and service provider sector, a field with which he is familiar. Prior to joining Pfizer, Hubbard headed up clinical research services at Icon ($ICLR). Release